Chloramphenicol 0.5%W/V eye drops 1%W/V ointment P medicine
The RPS has updated the Chloramphenicol 0.5%W/V eye drops 1%W/V ointment P medicine quick reference guide... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 18, 2018 Category: Drugs & Pharmacology Source Type: news

Your views sought on Falsified Medicines Directive consultation
The MHRA has published a consultation on several areas of the EU Falsified Medicines Directive (FMD).The consultation focuses on the safety features where the UK has flexibility within the Delegated A (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 17, 2018 Category: Drugs & Pharmacology Source Type: news

Public Health England: New Blood in Pee campaign
Public Health England's national campaign on Blood in Pee under the Be Clear on Cancer banner launches on 19th July 2018. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 17, 2018 Category: Drugs & Pharmacology Source Type: news

Company led recall: Melatonin 10mg capsules
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company led recall for specific batches of Melatonin 10mg capsules (IPS Specials). (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 17, 2018 Category: Drugs & Pharmacology Source Type: news

Pharmacy organisations brief MPs in Westminster
We are joining community pharmacy organisations in Parliament today to highlight the role that community pharmacy can play in helping people to support people with long-term conditions. With continue (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 17, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to Channel 4 about weight loss supplements
RPS Deputy Chief Scientist Dr Claire Thompson conducted experiments on Channel 4’s Food Unwrapped on Fridayto demonstrate how weight loss supplements work. Claire was interviewed as part of the (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 16, 2018 Category: Drugs & Pharmacology Source Type: news

CPPE launches The General Data Protection Regulation (GDPR) e-learning programme
CPPE has launched an e-learning programme‘The General Data Protection Regulation– making it work’. The aim of this e-learning programme is to develop awareness, understanding and s (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 13, 2018 Category: Drugs & Pharmacology Source Type: news

Online oral health promotion resources for national campaign 'Dental Check by One'
The Chief Dental Officer for England is promoting early dental access and preventive care for young children aged 0-2 years, in line with a national campaign for a‘Dental Check by One’&n (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 13, 2018 Category: Drugs & Pharmacology Source Type: news

RPS Wales welcomes Assembly Group findings on access to palliative care
The Royal Pharmaceutical Society in Wales has welcomed recommendations of the National Assembly for Wales's Cross Party Group on Hospices and Palliative Care report into inequalities in access to (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 12, 2018 Category: Drugs & Pharmacology Source Type: news

Medical device alert: All Alaris and Asena GS, GH, CC, TIVA, PK, enteral syringe pumps
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert for all Alaris and Asena GS, GH, CC, TIVA, PK, enteral syringe pumps because of a risk of uncontrolled (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 12, 2018 Category: Drugs & Pharmacology Source Type: news

Class 1 Medicines Recall: Action Now including out of hours Pharmacy Level Recall: Superseded drug alert - Valsartan/Hydrochlorothiazide 160/12.5mg Film-Coated Tablets
The Medicines& Healthcare products Regulatory Agency (MHRA) issued a Class 1 Medicines Recall (Drug Alert EL (18)A/11) on 5th July 2018. Pharmacies in the UK were asked to recall all batches of v (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 11, 2018 Category: Drugs & Pharmacology Source Type: news

RPS guidance on polypharmacy open for consultation
Polypharmacy– taking many medicines - can be a problem when patients end up being prescribed medicines for different conditions, which can cause problems and often remain on their prescription (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 10, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England responds to appointment of new Health Secretary
Responding on the appointment of Rt Hon Matthew Hancock MP as the new Secretary of State for Health and Social Care,Sandra Gidley, Chair of the English Pharmacy Board, said:"This is a crucial t (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 10, 2018 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines Recall: Fiasp FlexTouch 100 units/mL solution for injection pre-filled pen manufactured by Novo Nordisk
The Medicines and Healthcare products Regulatory Agency (MHRA) has issues a Class 2 medicines recall for one batch of Fiasp FlexTouch 100 units/ml solution for injection pre-filled pen manufactured by (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 9, 2018 Category: Drugs & Pharmacology Source Type: news

RPS in Scotland provides evidence to Scottish Labour NHS and Social Care Workforce Commission
We have published our written evidence to Scottish Labour’s NHS and Social Care Workforce Commission, chaired by Anas Sarwar, Shadow Cabinet Secretary for Health and Wellbeing. On 2 July we (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 9, 2018 Category: Drugs & Pharmacology Source Type: news

RPS warns against deadly diet pills online
The RPS is supporting a campaign to highlight the dangers of buying so-called diet pills online from rogue websites. #DyingToDiet from Free Radio aims to highlight how dangerous it is to buy these pr (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 7, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to Radio 5 Live about horsefly bites
The warm weather has led to an increase in bites by horseflies in Scotland as people spend more time outside with their skin exposed. Horsefly bites are painful and can, in some cases, become infecte (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 6, 2018 Category: Drugs & Pharmacology Source Type: news

RPS responds to news on state-backed indemnity scheme in general practice
Responding on the latest update from the Department of Health regarding a proposed state-backed indemnity scheme in general practice in England, Sandra Gidley, Chair of the English Pharmacy Board, sai (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 5, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England responds to news on state-backed indemnity scheme in general practice
Responding on the latest update from the Department of Health regarding a proposed state-backed indemnity scheme in general practice in England, Sandra Gidley, Chair of the English Pharmacy Board, sai (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 5, 2018 Category: Drugs & Pharmacology Source Type: news

Class 1 Medicines Recall: Action Now including out of hours Pharmacy Level Recall: Valsartan capsules and tablets
The Medicines& Healthcare products Regulatory Agency (MHRA) hasissued a Class 1 Medicines Recall. Pharmacies in the UK are being advised to recall all batches of valsartan containing medicines ma (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 5, 2018 Category: Drugs & Pharmacology Source Type: news

Combur10 Test UX and Chemstrip 10 A test strips – risk of falsely low results when measuring test strips on the Urisys 1100 urine analyser
Medicines Healthcare Regulatory Agency (MHRA) has issued a medicines device alert for Combur10 Test UX and Chemstrip 10 A test strips... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 5, 2018 Category: Drugs & Pharmacology Source Type: news

RPS in Scotland seeks member representative on the SIGN Council
An exciting opportunity has arisen for a member of the Royal Pharmaceutical Society (RPS) to represent RPS on the SIGN Council. Gary Cook Lead has held the voluntary post for two years and has recentl (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 5, 2018 Category: Drugs & Pharmacology Source Type: news

Celebrating 70 years of NHS pharmacy
Today the National Health Service is celebrating its 70th birthday. Ash Soni, President of the Royal Pharmaceutical Society said:“Pharmacists have played a vital role in providing NHS service (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 5, 2018 Category: Drugs & Pharmacology Source Type: news

Dr John McAnaw affirmed as Chair of the Scottish Pharmacy Board
The executive team of the Scottish Pharmacy Board has today been agreed. Dr John McAnaw was affirmed as Chair of the Board, which will be his last year of chairing the board following his election for (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 3, 2018 Category: Drugs & Pharmacology Source Type: news

Company led recall – Denzapine 50mg/ml oral suspension
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company led recall for specific batches of Denzapine 50mg/ml oral suspension (Britannia Pharmaceuticals Ltd), due to increas (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - July 2, 2018 Category: Drugs & Pharmacology Source Type: news

Harvinder Sondh MRPharmS is new RPS Director of Innovation & Enterprise
The Royal Pharmaceutical Society is pleased to announce the appointment of Harvinder Sondh MRPharmS as its new Director of Innovation& Enterprise. Harvinder Sondh is currently RPS Director of Ma (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 28, 2018 Category: Drugs & Pharmacology Source Type: news

Patient safety alert update: Update on the NHS Improvement patient safety alert - risk of death and severe harm from failure to obtain and continue flow from oxygen cylinders (January 2018)
NHS Improvement published a patient safety alert on 9 January 2018: Risk of death and severe harm from failure to obtain and continue flow from oxygen cylinders... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 28, 2018 Category: Drugs & Pharmacology Source Type: news

Insulin preparations: Regional Medicines Optimisation Committee (RMOC) recommendations of safety considerations for formulary decision making
The Regional Medicines Optimisation Committee (RMOC) programme has issued guidance to formulary committees and Area Prescribing Committees on recommendations of safety considerations for formulary dec (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 27, 2018 Category: Drugs & Pharmacology Source Type: news

NHS Improvement Patient Safety Alert
A resources alert has been produced by NHS Improvement to support safer modification of food and drink... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 27, 2018 Category: Drugs & Pharmacology Source Type: news

Support for pharmacy teams with valproate medicines
A joint resource has been published today to support pharmacy teams in helping women and girls who have been prescribed valproate medicines. Women and girls using valproate medicines must now be prot (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 25, 2018 Category: Drugs & Pharmacology Source Type: news

RPS calls for reclassification of cannabis for medicinal use
The RPS has published a policy statement recommending that cannabis be rescheduled from Schedule 1 to Schedule 2in the Misuse of Drugs Regulations 2001. RPS President Ash Soni has formally written to (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 22, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England Board meeting - June update
Commenting on the key outcomes from the Royal Pharmaceutical Society’s English Pharmacy Board meeting on 20-21 June, Board Chair Sandra Gidley said:“The Board unanimously supported a mot (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 22, 2018 Category: Drugs & Pharmacology Source Type: news

Medical device alert: Alaris Smartsite Add-On Bag Access device – removal and destruction of specific batches due to risk of disconnection or leakage
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device alert for specific batches of Alaris Smartsite Add-On Bag Access device ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 21, 2018 Category: Drugs & Pharmacology Source Type: news

Pharmacy CEOs offer support for NHS Assembly
The leaders of five national pharmacy organisations have sought involvement in a new stakeholder forum being created to oversee progress on developing long-term plans for the NHS. At a recent board m (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 21, 2018 Category: Drugs & Pharmacology Source Type: news

Medical device recall: Smiths Medical CADD Non Flow-Stop Medical Cassette Reservoirs
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device recall of specific lots of Smiths Medical CADD Non Flow-Stop Medical Cassette Reservoirs due to the risk of u (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 20, 2018 Category: Drugs & Pharmacology Source Type: news

Class 2 Medicines Recall: Own-brand children ’s glycerine and blackcurrant cough syrups manufactured by Bell, Sons & Co
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for Bell, Sons& Co... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 20, 2018 Category: Drugs & Pharmacology Source Type: news

Class 4 medicines defect information: Bleo-Kyowa Powder for Solution Injection 15,000IU
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Class 4 medicines defect information drug alert for Bleo-Kyowa, Powder for Solution Injection. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 19, 2018 Category: Drugs & Pharmacology Source Type: news

RPS welcomes consultation on hospital dispensing errors
The Royal Pharmaceutical Society has welcomed the start of a government consultation on changes to the law to provide a new defence on inadvertent dispensing errors in hospitals and other settings. T (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 19, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England responds to £20bn extra funding for NHS
Further to the announcement by the Prime Minister that the Government plans to increase the NHS budget by£20bn over the next five years, RPS England Board Chair Sandra Gidley said:"This (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 18, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to BBC about new diabetes toolkit for Ramadan
RPS England Board member Dr Mahendra Patel talked to BBC Look North recently about how pharmacists can help people manage their medicines during Ramadan. Mahendra has been closely involved with the d (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 12, 2018 Category: Drugs & Pharmacology Source Type: news

RPS Wales welcomes long term vision to transform care in Wales
RPS Wales has welcomed the publication of A Healthier Wales: Our Plan for Health and Social Care, the Welsh Government’s long term vision for the future of health and social care in Wales. Bu (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 11, 2018 Category: Drugs & Pharmacology Source Type: news

RPS talks to ITV News about the investment needed to develop drugs
Our Deputy Chief Scientist Dr Claire Thompson was interviewed by ITV News at Ten last night about the investment needed for drug development. Claire was giving context to a news story about Pfizer an (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 8, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England responds to National Audit Office report on generic pricing
Commenting on the report from the National Audit Office (NAO) into NHS spending on generic medicines in primary care, RPS England Board Chair Sandra Gidley said:“This NAO investigation brings (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 8, 2018 Category: Drugs & Pharmacology Source Type: news

New RPS Fellows Announced
Being appointed a Fellow of the Royal Pharmaceutical Society is one of the highest honours that can be bestowed upon Society Members. It recognises the distinction Members have attained in a particula (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 8, 2018 Category: Drugs & Pharmacology Source Type: news

Robbie Turner appointed RPS Director of Pharmacy and Member Experience
The Royal Pharmaceutical Society is pleased to announce the appointment of Robbie Turner FRPharmS as its new Director of Pharmacy& Member Experience. Robbie is currently RPS Director of England (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 8, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England calls for pharmacists to play bigger role in mental health care
The Royal Pharmaceutical Society in England is calling for pharmacists to be integrated into services providing care for people with mental health conditions to ensure patients receive the right care (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 6, 2018 Category: Drugs & Pharmacology Source Type: news

Regional Medicines Optimisation Committee (RMOC) briefing on adalimumab
NHS England Regional Medicines Optimisation Committee has published a briefing paper on adalimumab. The briefing provides a summary of advice on the next steps for commissioners and providers; practic (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 1, 2018 Category: Drugs & Pharmacology Source Type: news

Drug safety update: Braltus (tiotropium): risk of inhalation of capsule if placed in the mouthpiece of the inhaler
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update: Braltus (tiotropium): risk of inhalation of capsule if placed in the mouthpiece of the inhaler. Actions (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 30, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England welcomes Lord Carter's review into mental health and community sectors
Commenting on Lord Carter’s review NHS Operational Productivity: Unwarranted Variations - Mental Health Services, Community Health Services RPS England Board Chair Sandra Gidley said:“We (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 29, 2018 Category: Drugs & Pharmacology Source Type: news

RPS England talks to BBC Radio 4 about Epipen shortage
Director for England Robbie Turner talked to BBC Radio 4’s You& Yours today about the shortage of Epipens. An Epipenis an adrenaline injection used to treat the allergic reaction anaphylax (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - May 24, 2018 Category: Drugs & Pharmacology Source Type: news